Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway.
Nakamuta M, Fujino T, Yada R, Yasutake K, Yoshimoto T, Harada N, Yada M, Higuchi N, Kato M, Kohjima M, Taketomi A, Maehara Y, Nishinakagawa T, Machida K, Matsunaga K, Nakashima M, Kotoh K, Enjoji M.
Nakamuta M, et al.
Int J Clin Pharmacol Ther. 2010 Jan;48(1):22-8. doi: 10.5414/cpp48022.
Int J Clin Pharmacol Ther. 2010.
PMID: 20040336
Clinical Trial.